These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15229305)

  • 1. Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
    Vasan RS; Evans JC; Larson MG; Wilson PW; Meigs JB; Rifai N; Benjamin EJ; Levy D
    N Engl J Med; 2004 Jul; 351(1):33-41. PubMed ID: 15229305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.
    Newton-Cheh C; Guo CY; Gona P; Larson MG; Benjamin EJ; Wang TJ; Kathiresan S; O'Donnell CJ; Musone SL; Camargo AL; Drake JA; Levy D; Hirschhorn JN; Vasan RS
    Hypertension; 2007 Apr; 49(4):846-56. PubMed ID: 17296870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study.
    Lago RM; Pencina MJ; Wang TJ; Lanier KJ; D'Agostino RB; Kannel WB; Vasan RS
    J Hypertens; 2008 Nov; 26(11):2121-5. PubMed ID: 18854750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
    Brown JM; Robinson-Cohen C; Luque-Fernandez MA; Allison MA; Baudrand R; Ix JH; Kestenbaum B; de Boer IH; Vaidya A
    Ann Intern Med; 2017 Nov; 167(9):630-641. PubMed ID: 29052707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study.
    Freitag MH; Larson MG; Levy D; Benjamin EJ; Wang TJ; Leip EP; Wilson PW; Vasan RS;
    Hypertension; 2003 Apr; 41(4):978-83. PubMed ID: 12623868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study.
    Vasan RS; Evans JC; Benjamin EJ; Levy D; Larson MG; Sundstrom J; Murabito JM; Sam F; Colucci WS; Wilson PW
    Hypertension; 2004 May; 43(5):957-62. PubMed ID: 15007028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone.
    Jin Y; Kuznetsova T; Maillard M; Richart T; Thijs L; Bochud M; Herregods MC; Burnier M; Fagard R; Staessen JA
    Hypertension; 2009 Sep; 54(3):489-95. PubMed ID: 19581508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade albuminuria and the risks of hypertension and blood pressure progression.
    Wang TJ; Evans JC; Meigs JB; Rifai N; Fox CS; D'Agostino RB; Levy D; Vasan RS
    Circulation; 2005 Mar; 111(11):1370-6. PubMed ID: 15738353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
    Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD;
    Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.
    Bikkina M; Levy D; Evans JC; Larson MG; Benjamin EJ; Wolf PA; Castelli WP
    JAMA; 1994 Jul; 272(1):33-6. PubMed ID: 8007076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study.
    Post WS; Larson MG; Levy D
    Circulation; 1994 Jul; 90(1):179-85. PubMed ID: 8025994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.
    Sundström J; Sullivan L; D'Agostino RB; Levy D; Kannel WB; Vasan RS
    Hypertension; 2005 Jan; 45(1):28-33. PubMed ID: 15569852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk.
    Abad-Cardiel M; Alvarez-Álvarez B; Luque-Fernandez L; Fernández C; Fernández-Cruz A; Martell-Claros N
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):47-52. PubMed ID: 23153688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
    Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
    J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study.
    Sundström J; Sullivan L; D'Agostino RB; Jacques PF; Selhub J; Rosenberg IH; Wilson PW; Levy D; Vasan RS
    Hypertension; 2003 Dec; 42(6):1100-5. PubMed ID: 14597642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
    du Cailar G; Fesler P; Ribstein J; Mimran A
    Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.